Geode Capital Management’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.96M | Buy |
1,745,176
+887,218
| +103% | +$2.01M | ﹤0.01% | 2851 |
|
|
2025
Q1 | $546K | Buy |
857,958
+42,315
| +5% | +$26.9K | ﹤0.01% | 3508 |
|
|
2024
Q4 | $840K | Buy |
815,643
+12,112
| +2% | +$12.5K | ﹤0.01% | 3428 |
|
|
2024
Q3 | $948K | Buy |
803,531
+34,032
| +4% | +$40.2K | ﹤0.01% | 3370 |
|
|
2024
Q2 | $939K | Buy |
769,499
+16,101
| +2% | +$19.6K | ﹤0.01% | 3330 |
|
|
2024
Q1 | $1.64M | Buy |
753,398
+50,744
| +7% | +$111K | ﹤0.01% | 3190 |
|
|
2023
Q4 | $1.09M | Buy |
702,654
+26,311
| +4% | +$40.8K | ﹤0.01% | 3327 |
|
|
2023
Q3 | $873K | Buy |
676,343
+32,256
| +5% | +$41.6K | ﹤0.01% | 3382 |
|
|
2023
Q2 | $1.11M | Buy |
644,087
+1,779
| +0.3% | +$3.06K | ﹤0.01% | 3305 |
|
|
2023
Q1 | $970K | Buy |
642,308
+39,233
| +7% | +$59.2K | ﹤0.01% | 3362 |
|
|
2022
Q4 | $964K | Buy |
603,075
+15,624
| +3% | +$25K | ﹤0.01% | 3355 |
|
|
2022
Q3 | $851K | Buy |
587,451
+4,386
| +0.8% | +$6.35K | ﹤0.01% | 3476 |
|
|
2022
Q2 | $1.07M | Sell |
583,065
-467,083
| -44% | -$855K | ﹤0.01% | 3393 |
|
|
2022
Q1 | $2.8M | Sell |
1,050,148
-123,699
| -11% | -$330K | ﹤0.01% | 3078 |
|
|
2021
Q4 | $5.08M | Buy |
1,173,847
+50,764
| +5% | +$220K | ﹤0.01% | 2894 |
|
|
2021
Q3 | $5.72M | Sell |
1,123,083
-29,927
| -3% | -$152K | ﹤0.01% | 2833 |
|
|
2021
Q2 | $7.3M | Buy |
1,153,010
+75,392
| +7% | +$477K | ﹤0.01% | 2678 |
|
|
2021
Q1 | $8.33M | Buy |
1,077,618
+319,304
| +42% | +$2.47M | ﹤0.01% | 2478 |
|
|
2020
Q4 | $4.97M | Buy |
758,314
+5,150
| +0.7% | +$33.7K | ﹤0.01% | 2608 |
|
|
2020
Q3 | $5.01M | Buy |
753,164
+44,275
| +6% | +$294K | ﹤0.01% | 2398 |
|
|
2020
Q2 | $5.91M | Buy |
708,889
+3,702
| +0.5% | +$30.8K | ﹤0.01% | 2236 |
|
|
2020
Q1 | $5.41M | Buy |
705,187
+48,930
| +7% | +$375K | ﹤0.01% | 2102 |
|
|
2019
Q4 | $5.45M | Buy |
656,257
+39,211
| +6% | +$326K | ﹤0.01% | 2397 |
|
|
2019
Q3 | $4.55M | Buy |
617,046
+18,055
| +3% | +$133K | ﹤0.01% | 2436 |
|
|
2019
Q2 | $6.72M | Buy |
598,991
+2,177
| +0.4% | +$24.4K | ﹤0.01% | 2205 |
|
|
2019
Q1 | $6.42M | Buy |
596,814
+29,913
| +5% | +$322K | ﹤0.01% | 2183 |
|
|
2018
Q4 | $8.56M | Buy |
566,901
+52,736
| +10% | +$796K | ﹤0.01% | 1878 |
|
|
2018
Q3 | $9.51M | Buy |
514,165
+151,037
| +42% | +$2.79M | ﹤0.01% | 1962 |
|
|
2018
Q2 | $8.3M | Buy |
363,128
+32,854
| +10% | +$751K | ﹤0.01% | 2022 |
|
|
2018
Q1 | $9.4M | Sell |
330,274
-17,199
| -5% | -$489K | ﹤0.01% | 1816 |
|
|
2017
Q4 | $7.33M | Buy |
347,473
+21,548
| +7% | +$455K | ﹤0.01% | 1964 |
|
|
2017
Q3 | $5.92M | Buy |
325,925
+91,162
| +39% | +$1.66M | ﹤0.01% | 2094 |
|
|
2017
Q2 | $3.64M | Buy |
234,763
+26,053
| +12% | +$404K | ﹤0.01% | 2367 |
|
|
2017
Q1 | $3.6M | Buy |
208,710
+16,991
| +9% | +$293K | ﹤0.01% | 2306 |
|
|
2016
Q4 | $2.11M | Buy |
191,719
+11,058
| +6% | +$121K | ﹤0.01% | 2597 |
|
|
2016
Q3 | $2.83M | Buy |
180,661
+104,547
| +137% | +$1.64M | ﹤0.01% | 2338 |
|
|
2016
Q2 | $777K | Buy |
76,114
+7,860
| +12% | +$80.2K | ﹤0.01% | 3016 |
|
|
2016
Q1 | $880 | Buy |
68,254
+10,184
| +18% | +$131 | ﹤0.01% | 2949 |
|
|
2015
Q4 | $1.21M | Buy |
+58,070
| New | +$1.21M | ﹤0.01% | 2798 |
|